Concepedia

Glykeria Tzatzagou

GT

Statistics

Publications

8

Citations

2.4K

H-Index

8

Active since

2018

Affiliations

Aristotle University of Thessaloniki(Current)

Papageorgiou General Hospital

Ospedale Sacro Cuore Don Calabria

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

University of Patras

Glykeria Tzatzagou is an author at Aristotle University of Thessaloniki specializing in diabetes, clinical trials, and outcomes research.

Top concepts

Publications per year

2018–2024

8

Publications

8

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

, , +6

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou, Haralampos Milionis, Symeon Metallidis et al. · Nature Medicine · 2021 · 518 citations · Full text

Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial

Eirini Papadopoulou, Charalampos Loutradis, Glykeria Tzatzagou et al. · Journal of Hypertension · 2020 · 63 citations

Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure

Evangelos J. Giamarellos‐Bourboulis, Aline de Nooijer, Haralampos Milionis et al. · Cell Reports Medicine · 2022 · 37 citations · Full text

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trial

Karolina Akinosoglou, Antigone Kotsaki, Maria Ioanna Gounaridi et al. · EClinicalMedicine · 2022 · 22 citations · Full text

Rows per page

1–5 of 8